GSK Seeks Dismissal Of 27 Zofran Birth Defect MDL Cases Involving Generics

Mealey's (October 17, 2016, 1:00 PM EDT) -- BOSTON — GlaxoSmithKline LLC (GSK) on Oct. 13 asked the Zofran birth defect multidistrict litigation court to dismiss 27 cases in which plaintiffs allege injuries from taking one of the drug’s...
To view the full article, register now.